Xintai Medical (02291.HK) announced its interim results with a net profit attributable to parent of 182 million yuan, an increase of 29.81% year-on-year.

Wisdom Wealth Finance APP News, Xintai Medical (02291.HK) released its interim performance for the six months ending on June 30, 2025. The total operating income was 330 million yuan, an increase of 32.36% year-on-year; net profit attributable to shareholders was 182 million yuan, an increase of 29.81% year-on-year; basic earnings per share were 0.5249 yuan.